An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 6, 2008, Pages 506-511

  Sharma, Praveen ^a   Sharma, Barjesh C ^a   Puri, Vinod ^a   Sarin, Shiv Kumar ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Lactulose; Minimal hepatic encephalopathy; Probiotics

Indexed keywords

AMMONIA; LACTULOSE; PROBIOTIC AGENT;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BACILLUS PUMILUS; CLINICAL TRIAL; CLOSTRIDIUM BUTYRICUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AMMONIA; DRUG THERAPY, COMBINATION; EVENT-RELATED POTENTIALS, P300; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LACTULOSE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROBIOTICS; PSYCHOMETRICS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 43449114798     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f3e6f5     Document Type: Article

References (24)